Cargando…
The driver role of JAK‐STAT signalling in cancer stemness capabilities leading to new therapeutic strategies for therapy‐ and castration‐resistant prostate cancer
BACKGROUND: Lineage plasticity in prostate cancer (PCa) has emerged as an important mechanism leading to the onset of therapy‐ and castration‐resistant PCa (t‐CRPC), which is closely associated with cancer stem cell (CSC) activity. This study is to identify critical driver(s) with mechanism of actio...
Autores principales: | Lo, U‐Ging, Chen, Yu‐An, Cen, Junjie, Deng, Su, Luo, Junghang, Zhau, Haiyen, Ho, Lin, Lai, Chih‐Ho, Mu, Ping, Chung, Leland W.K., Hsieh, Jer‐Tsong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9339240/ https://www.ncbi.nlm.nih.gov/pubmed/35908276 http://dx.doi.org/10.1002/ctm2.978 |
Ejemplares similares
-
The central role of Sphingosine kinase 1 in the development of neuroendocrine prostate cancer (NEPC): A new targeted therapy of NEPC
por: Lee, Cheng‐Fan, et al.
Publicado: (2022) -
Multiplexed Quantum Dot Labeling of Activated c-Met Signaling in Castration-Resistant Human Prostate Cancer
por: Hu, Peizhen, et al.
Publicado: (2011) -
Developing New Treatment Options for Castration-Resistant Prostate Cancer and Recurrent Disease
por: Wang, Bo-Ren, et al.
Publicado: (2022) -
Upregulation of minichromosome maintenance complex component 3 during epithelial-to-mesenchymal transition in human prostate cancer
por: Stewart, Paul A., et al.
Publicado: (2017) -
Evolving Personalized Therapy for Castration-Resistant Prostate Cancer
por: Liu, Hsin-Ho, et al.
Publicado: (2014)